In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.
Ananworanich
Jintanat
J
Nuesch
Reto
R
Teeratakulpisarn
Somsong
S
Srasuebkul
Preeyaporn
P
Chuenyam
Theshinee
T
Siangphoe
Umaporn
U
Ungsedhaphand
Chaiwat
C
Phanuphak
Praphan
P
Ruxrungtham
Kiat
K
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003430:Cross-Sectional Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral